NR 567 Advanced Pharmacology Midterm
Exam150 High-Yield Practice Questions, Verified
Answers, and Clinical Rationales | INSTANT PDF
DOWNLOAD
Course Introduction
NR 567 is a foundational course for Advanced Practice Nurses, bridging the gap between basic pharmacology and
clinical application. The midterm exam typically covers Chapters 1 through 20, moving from the foundational "how
drugs work" (Kinetics/Dynamics) into the heavy-hitting systemic drug classes like the Autonomic Nervous System
and Cardiovascular therapy.
Core Study Domains Included:
Pharmacokinetics & Pharmacodynamics: Absorption, distribution, CYP450 metabolism (inducers vs. inhibitors),
excretion, and the dose-response relationship.
Autonomic Nervous System (ANS): Deep dive into Adrenergic (Alpha/Beta) and Cholinergic (Muscarinic/Nicotinic)
receptors, including agonists and antagonists.
Cardiovascular Pharmacology: Management of Hypertension, Heart Failure, Dyslipidemia, and Arrhythmias
(ACEIs, ARBs, CCBs, Beta-blockers, Statins, and Diuretics).
Hematologic Agents: Anticoagulants (Warfarin/Heparin/DOACs), antiplatelets, and their respective reversal agents.
Endocrine Management: Comprehensive diabetes care (Insulins, Metformin, GLP-1s, SGLT2s) and Thyroid
hormone regulation.
Antibiotic Foundations: Mechanisms of action (Cell wall vs. Protein synthesis inhibitors), resistance patterns, and
major toxicities (Oto/Nephro/Photosensitivity).
1. Which process describes the movement of a drug from its site of administration into the
blood?
,A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Explanation: Absorption is the primary step where a drug enters the systemic
circulation. Factors like lipid solubility and blood flow at the site influence this rate.
2. The "First-Pass Effect" refers to the rapid inactivation of some oral drugs as they
pass through the:
A) Liver
B) Kidneys
C) Small Intestine
D) Lungs
Explanation: Drugs absorbed from the GI tract are carried to the liver via the
hepatic portal vein. If the liver has a high capacity to metabolize the drug, it may be
inactivated before reaching systemic circulation.
3. A drug with a high "Therapeutic Index" (TI) is considered:
A) Relatively safe
B) Highly toxic
C) Potent
D) Fast-acting
Explanation: The Therapeutic Index is the ratio of the toxic dose to the effective
dose. A higher number means there is a larger "margin of safety" between the dose that
works and the dose that kills.
4. Which Cytochrome P450 (CYP) enzyme is responsible for metabolizing
approximately 50% of all clinically used drugs?
A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C19
Explanation: CYP3A4 is the most abundant and clinically significant isoenzyme
in the liver and intestinal tract.
,5. What happens to the "Half-Life" ) of a drug in a patient with significant renal
failure?
A) It increases
B) It decreases
C) It remains the same
D) It becomes zero
Explanation: Half-life is the time required for the amount of drug in the body to
decrease by 50%. Reduced renal excretion slows the removal of the drug, extending its
stay in the body.
6. A "Pro-drug" is defined as a compound that:
A) Works immediately upon ingestion
B) Is pharmacologically inactive until metabolized by the liver
C) Is only given via IV
D) Has no side effects
Explanation: Pro-drugs (like Enalapril or Codeine) require metabolic conversion
to become active metabolites.
7. Which route of administration provides 100% bioavailability?
A) Oral (PO)
B) Subcutaneous (SQ)
C) Intravenous (IV)
D) Intramuscular (IM)
Explanation: Bioavailability is the fraction of administered drug that reaches
systemic circulation. IV skips absorption and the first-pass effect entirely.
8. When an "Agonist" binds to a receptor, it:
A) Mimics the action of endogenous regulatory molecules
B) Blocks the action of endogenous molecules
C) Prevents the receptor from working
D) Decreases the receptor's sensitivity
Explanation: Agonists have both affinity (can bind) and high intrinsic activity
(can trigger a response).
9. "Steady State" is typically achieved after how many half-lives of a drug?
A) 1–2
, B) 2–3
C) 4–5
D) 8–10
Explanation: At 4 to 5 half-lives, the amount of drug eliminated equals the
amount being administered.
10. The primary protein in the plasma that binds to acidic drugs is:
A) Albumin
B) Hemoglobin
C) Gamma globulin
D) Lipoprotein
Explanation: Albumin is the most important protein for drug binding. If albumin
levels are low (malnutrition), free drug levels increase, potentially leading to toxicity.
11. Stimulation of the Sympathetic Nervous System results in:
A) Bradycardia
B) Tachycardia and bronchodilation
C) Increased GI motility
D) Pupillary constriction (miosis)
Explanation: The "Fight or Flight" response increases heart rate and opens
airways to maximize oxygenation.
12. Bethanechol is a Cholinergic Agonist primarily used for:
A) Diarrhea
B) Urinary retention
C) Hypertension
D) Dry mouth
Explanation: Bethanechol stimulates muscarinic receptors of the urinary tract,
causing contraction of the detrusor muscle and relaxation of the sphincter to allow
voiding.
13. Which receptor is responsible for increasing heart rate and contractility?
A) Alpha-1
B) Alpha-2
C) Beta-1
D) Beta-2
Exam150 High-Yield Practice Questions, Verified
Answers, and Clinical Rationales | INSTANT PDF
DOWNLOAD
Course Introduction
NR 567 is a foundational course for Advanced Practice Nurses, bridging the gap between basic pharmacology and
clinical application. The midterm exam typically covers Chapters 1 through 20, moving from the foundational "how
drugs work" (Kinetics/Dynamics) into the heavy-hitting systemic drug classes like the Autonomic Nervous System
and Cardiovascular therapy.
Core Study Domains Included:
Pharmacokinetics & Pharmacodynamics: Absorption, distribution, CYP450 metabolism (inducers vs. inhibitors),
excretion, and the dose-response relationship.
Autonomic Nervous System (ANS): Deep dive into Adrenergic (Alpha/Beta) and Cholinergic (Muscarinic/Nicotinic)
receptors, including agonists and antagonists.
Cardiovascular Pharmacology: Management of Hypertension, Heart Failure, Dyslipidemia, and Arrhythmias
(ACEIs, ARBs, CCBs, Beta-blockers, Statins, and Diuretics).
Hematologic Agents: Anticoagulants (Warfarin/Heparin/DOACs), antiplatelets, and their respective reversal agents.
Endocrine Management: Comprehensive diabetes care (Insulins, Metformin, GLP-1s, SGLT2s) and Thyroid
hormone regulation.
Antibiotic Foundations: Mechanisms of action (Cell wall vs. Protein synthesis inhibitors), resistance patterns, and
major toxicities (Oto/Nephro/Photosensitivity).
1. Which process describes the movement of a drug from its site of administration into the
blood?
,A) Distribution
B) Metabolism
C) Absorption
D) Excretion
Explanation: Absorption is the primary step where a drug enters the systemic
circulation. Factors like lipid solubility and blood flow at the site influence this rate.
2. The "First-Pass Effect" refers to the rapid inactivation of some oral drugs as they
pass through the:
A) Liver
B) Kidneys
C) Small Intestine
D) Lungs
Explanation: Drugs absorbed from the GI tract are carried to the liver via the
hepatic portal vein. If the liver has a high capacity to metabolize the drug, it may be
inactivated before reaching systemic circulation.
3. A drug with a high "Therapeutic Index" (TI) is considered:
A) Relatively safe
B) Highly toxic
C) Potent
D) Fast-acting
Explanation: The Therapeutic Index is the ratio of the toxic dose to the effective
dose. A higher number means there is a larger "margin of safety" between the dose that
works and the dose that kills.
4. Which Cytochrome P450 (CYP) enzyme is responsible for metabolizing
approximately 50% of all clinically used drugs?
A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C19
Explanation: CYP3A4 is the most abundant and clinically significant isoenzyme
in the liver and intestinal tract.
,5. What happens to the "Half-Life" ) of a drug in a patient with significant renal
failure?
A) It increases
B) It decreases
C) It remains the same
D) It becomes zero
Explanation: Half-life is the time required for the amount of drug in the body to
decrease by 50%. Reduced renal excretion slows the removal of the drug, extending its
stay in the body.
6. A "Pro-drug" is defined as a compound that:
A) Works immediately upon ingestion
B) Is pharmacologically inactive until metabolized by the liver
C) Is only given via IV
D) Has no side effects
Explanation: Pro-drugs (like Enalapril or Codeine) require metabolic conversion
to become active metabolites.
7. Which route of administration provides 100% bioavailability?
A) Oral (PO)
B) Subcutaneous (SQ)
C) Intravenous (IV)
D) Intramuscular (IM)
Explanation: Bioavailability is the fraction of administered drug that reaches
systemic circulation. IV skips absorption and the first-pass effect entirely.
8. When an "Agonist" binds to a receptor, it:
A) Mimics the action of endogenous regulatory molecules
B) Blocks the action of endogenous molecules
C) Prevents the receptor from working
D) Decreases the receptor's sensitivity
Explanation: Agonists have both affinity (can bind) and high intrinsic activity
(can trigger a response).
9. "Steady State" is typically achieved after how many half-lives of a drug?
A) 1–2
, B) 2–3
C) 4–5
D) 8–10
Explanation: At 4 to 5 half-lives, the amount of drug eliminated equals the
amount being administered.
10. The primary protein in the plasma that binds to acidic drugs is:
A) Albumin
B) Hemoglobin
C) Gamma globulin
D) Lipoprotein
Explanation: Albumin is the most important protein for drug binding. If albumin
levels are low (malnutrition), free drug levels increase, potentially leading to toxicity.
11. Stimulation of the Sympathetic Nervous System results in:
A) Bradycardia
B) Tachycardia and bronchodilation
C) Increased GI motility
D) Pupillary constriction (miosis)
Explanation: The "Fight or Flight" response increases heart rate and opens
airways to maximize oxygenation.
12. Bethanechol is a Cholinergic Agonist primarily used for:
A) Diarrhea
B) Urinary retention
C) Hypertension
D) Dry mouth
Explanation: Bethanechol stimulates muscarinic receptors of the urinary tract,
causing contraction of the detrusor muscle and relaxation of the sphincter to allow
voiding.
13. Which receptor is responsible for increasing heart rate and contractility?
A) Alpha-1
B) Alpha-2
C) Beta-1
D) Beta-2
